GRI Bio

GRI

GRI GRI Bio NASDAQ
Add to watchlist
--
At close :
--
  • Post market
  • Summary
    Financials
    News
    Filings
    Profile
    GRI Chart
    See on advanced chart >

    About

    GRI Bio, Inc. was incorporated under the laws of the State of Delaware in January 11, 2018. GRI Bio is a clinical stage biopharmaceutical company focused on fundamentally changing the way inflammatory, fibrotic and autoimmune diseases are treated. GRI's...
    • Highlight
      A clinical-stage biopharmaceutical company that develops novel drugs to deter abuse in the treatment of central nervous system disorders
    • Industry
    • Exchange
      NASDAQ
    • Listing Date
      02/10/2021
    • Established Date
      01/11/2018
    • Full-time Employees
      4
    • Address
      2223 Avenida de la Playa #208 La Jolla CA 92037
    • Tel
      1-619-4001170
    • Website
    • Fiscal Year End Date
      12/31
    • Security Type
      Common Stock